ID   CSKP_RAT                Reviewed;         909 AA.
AC   Q62915;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUL-2024, entry version 200.
DE   RecName: Full=Peripheral plasma membrane protein CASK {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:O14936};
DE   AltName: Full=Calcium/calmodulin-dependent serine protein kinase;
GN   Name=Cask {ECO:0000312|RGD:62004};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH NEUREXINS, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8786425; DOI=10.1523/jneurosci.16-08-02488.1996;
RA   Hata Y., Butz S., Suedhof T.C.;
RT   "CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent
RT   protein kinase domain identified by interaction with neurexins.";
RL   J. Neurosci. 16:2488-2494(1996).
RN   [2]
RP   INTERACTION WITH APBA1 AND LIN7.
RC   TISSUE=Testis;
RX   PubMed=9753324; DOI=10.1016/s0092-8674(00)81736-5;
RA   Butz S., Okamoto M., Suedhof T.C.;
RT   "A tripartite protein complex with the potential to couple synaptic vesicle
RT   exocytosis to cell adhesion in brain.";
RL   Cell 94:773-782(1998).
RN   [3]
RP   FUNCTION, INTERACTION WITH TBR1, AND SUBCELLULAR LOCATION.
RX   PubMed=10749215; DOI=10.1038/35005118;
RA   Hsueh Y.P., Wang T.F., Yang F.C., Sheng M.;
RT   "Nuclear translocation and transcription regulation by the membrane-
RT   associated guanylate kinase CASK/LIN-2.";
RL   Nature 404:298-302(2000).
RN   [4]
RP   INTERACTION WITH CASKIN1; LIN7A; LIN7B; LIN7C; APBA1 AND NRXN1.
RX   PubMed=12040031; DOI=10.1523/jneurosci.22-11-04264.2002;
RA   Tabuchi K., Biederer T., Butz S., Suedhof T.C.;
RT   "CASK participates in alternative tripartite complexes in which Mint 1
RT   competes for binding with Caskin 1, a novel CASK-binding protein.";
RL   J. Neurosci. 22:4264-4273(2002).
RN   [5]
RP   INTERACTION WITH DLG1 AND DLG4.
RX   PubMed=12151521; DOI=10.1523/jneurosci.22-15-06415.2002;
RA   Chetkovich D.M., Bunn R.C., Kuo S.-H., Kawasaki Y., Kohwi M., Bredt D.S.;
RT   "Postsynaptic targeting of alternative postsynaptic density-95 isoforms by
RT   distinct mechanisms.";
RL   J. Neurosci. 22:6415-6425(2002).
RN   [6]
RP   INTERACTION WITH DLG1.
RX   PubMed=11865057; DOI=10.1128/mcb.22.6.1778-1791.2002;
RA   Lee S., Fan S., Makarova O., Straight S., Margolis B.;
RT   "A novel and conserved protein-protein interaction domain of mammalian Lin-
RT   2/CASK binds and recruits SAP97 to the lateral surface of epithelia.";
RL   Mol. Cell. Biol. 22:1778-1791(2002).
RN   [7]
RP   INTERACTION WITH WHRN, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12641734; DOI=10.1046/j.1471-4159.2003.01647.x;
RA   Yap C.C., Liang F., Yamazaki Y., Muto Y., Kishida H., Hayashida T.,
RA   Hashikawa T., Yano R.;
RT   "CIP98, a novel PDZ domain protein, is expressed in the central nervous
RT   system and interacts with calmodulin-dependent serine kinase.";
RL   J. Neurochem. 85:123-134(2003).
RN   [8]
RP   INTERACTION WITH FCHSD2.
RX   PubMed=14627983; DOI=10.1038/sj.onc.1206996;
RA   Ohno H., Hirabayashi S., Kansaku A., Yao I., Tajima M., Nishimura W.,
RA   Ohnishi H., Mashima H., Fujita T., Omata M., Hata Y.;
RT   "Carom: a novel membrane-associated guanylate kinase-interacting protein
RT   with two SH3 domains.";
RL   Oncogene 22:8422-8431(2003).
RN   [9]
RP   IDENTIFICATION IN A COMPLEX WITH ACTN4; IQGAP1; MAGI2; NPHS1; SPTAN1 AND
RP   SPTBN1, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Renal glomerulus;
RX   PubMed=15994232; DOI=10.1073/pnas.0504166102;
RA   Lehtonen S., Ryan J.J., Kudlicka K., Iino N., Zhou H., Farquhar M.G.;
RT   "Cell junction-associated proteins IQGAP1, MAGI-2, CASK, spectrins, and
RT   alpha-actinin are components of the nephrin multiprotein complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9814-9819(2005).
RN   [10]
RP   INTERACTION WITH NRXN1.
RX   PubMed=25385611; DOI=10.1073/pnas.1416515111;
RA   Li Y., Wei Z., Yan Y., Wan Q., Du Q., Zhang M.;
RT   "Structure of Crumbs tail in complex with the PALS1 PDZ-SH3-GK tandem
RT   reveals a highly specific assembly mechanism for the apical Crumbs
RT   complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:17444-17449(2014).
RN   [11]
RP   STRUCTURE BY NMR OF 339-394 IN COMPLEX WITH DLG1.
RX   PubMed=15048107; DOI=10.1038/nsmb751;
RA   Feng W., Long J.F., Fan J.S., Suetake T., Zhang M.;
RT   "The tetrameric L27 domain complex as an organization platform for
RT   supramolecular assemblies.";
RL   Nat. Struct. Mol. Biol. 11:475-480(2004).
CC   -!- FUNCTION: Multidomain scaffolding Mg(2+)-independent protein kinase
CC       that catalyzes the phosphotransfer from ATP to proteins such as NRXN1,
CC       and plays a role in synaptic transmembrane protein anchoring and ion
CC       channel trafficking (By similarity). Multidomain scaffolding protein
CC       with a role in synaptic transmembrane protein anchoring and ion channel
CC       trafficking.ontributes to neural development and regulation of gene
CC       expression via interaction with the transcription factor TBR1. Binds to
CC       cell-surface proteins, including amyloid precursor protein, neurexins,
CC       and syndecans. May mediate a link between the extracellular matrix and
CC       the actin cytoskeleton via its interaction with syndecan and with the
CC       actin/spectrin-binding protein 4.1. Component of the LIN-10-LIN-2-LIN-7
CC       complex, which associates with the motor protein KIF17 to transport
CC       vesicles containing N-methyl-D-aspartate (NMDA) receptor subunit NR2B
CC       along microtubules (By similarity). {ECO:0000250|UniProtKB:O14936,
CC       ECO:0000250|UniProtKB:O70589, ECO:0000269|PubMed:10749215}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:O14936};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000250|UniProtKB:O14936};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- COFACTOR:
CC       Note=Unlike other protein kinases, does not require a divalent cation
CC       such as magnesium for catalytic activity. {ECO:0000250};
CC   -!- ACTIVITY REGULATION: Differs from archetypal CaMK members in that the
CC       kinase domain exhibits a constitutively active conformation and the
CC       autoinhibitory region does not engage in direct contact with the ATP-
CC       binding cleft, although it still binds Ca(2+)/CAM. {ECO:0000250}.
CC   -!- SUBUNIT: CASK and LIN7 form two mutually exclusive tripartite complexes
CC       with APBA1 or CASKIN1 (PubMed:12040031). Component of the brain-
CC       specific heterotrimeric complex (LIN-10-LIN-2-LIN-7 complex) composed
CC       of at least APBA1, CASK, and LIN7, which associates with the motor
CC       protein KIF17 to transport vesicles along microtubules (By similarity).
CC       Forms a heterotrimeric complex with DLG1 and LIN7B via their L27
CC       domains (By similarity). Identified in a complex with ACTN4, IQGAP1,
CC       MAGI2, NPHS1, SPTAN1 and SPTBN1 (PubMed:15994232). Part of a complex
CC       containing CASK, TBR1 and TSPYL2 (By similarity). Interacts with WHRN
CC       (PubMed:12641734). Interacts (via the PDZ, SH3 and guanylate kinase-
CC       like domains) with NRXN1 (via C-terminus) (PubMed:25385611,
CC       PubMed:8786425). Interacts with CASKIN1, APBA1, LIN7(A/B/C), and L27
CC       domain of DLG1 and isoform 2 of DLG4 (PubMed:11865057, PubMed:12040031,
CC       PubMed:12151521, PubMed:15048107, PubMed:9753324). Interacts with
CC       FCHSD2 (PubMed:14627983). Interacts with KIRREL3 (By similarity).
CC       Interacts with TBR1 (PubMed:10749215). Interacts with TSPYL2 (By
CC       similarity). {ECO:0000250|UniProtKB:O14936,
CC       ECO:0000250|UniProtKB:O70589, ECO:0000269|PubMed:10749215,
CC       ECO:0000269|PubMed:11865057, ECO:0000269|PubMed:12040031,
CC       ECO:0000269|PubMed:12151521, ECO:0000269|PubMed:12641734,
CC       ECO:0000269|PubMed:14627983, ECO:0000269|PubMed:15048107,
CC       ECO:0000269|PubMed:15994232, ECO:0000269|PubMed:25385611,
CC       ECO:0000269|PubMed:8786425, ECO:0000269|PubMed:9753324}.
CC   -!- INTERACTION:
CC       Q62915; O94868: FCHSD2; Xeno; NbExp=2; IntAct=EBI-704635, EBI-1215612;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10749215}. Cytoplasm
CC       {ECO:0000269|PubMed:12641734, ECO:0000269|PubMed:15994232}. Cell
CC       membrane {ECO:0000269|PubMed:14627983}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:14627983}.
CC   -!- TISSUE SPECIFICITY: Expressed in the foot process layer of podocytes in
CC       the kidney glomerulus and in tubules (at protein level). Detected in
CC       brain and neurons. {ECO:0000269|PubMed:12641734,
CC       ECO:0000269|PubMed:15994232, ECO:0000269|PubMed:8786425}.
CC   -!- DOMAIN: The first L27 domain binds DLG1 and the second L27 domain
CC       probably binds LIN7. {ECO:0000250}.
CC   -!- DOMAIN: The protein kinase domain mediates the interaction with FCHSD2.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the protein kinase
CC       superfamily. CAMK Ser/Thr protein kinase family. CaMK subfamily.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the MAGUK family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U47110; AAB19127.1; -; mRNA.
DR   RefSeq; NP_071520.1; NM_022184.1.
DR   PDB; 1RSO; NMR; -; B/D=339-394.
DR   PDB; 6LNM; X-ray; 2.40 A; A/C/E=1-345.
DR   PDBsum; 1RSO; -.
DR   PDBsum; 6LNM; -.
DR   AlphaFoldDB; Q62915; -.
DR   SMR; Q62915; -.
DR   BioGRID; 248269; 12.
DR   CORUM; Q62915; -.
DR   ELM; Q62915; -.
DR   IntAct; Q62915; 8.
DR   MINT; Q62915; -.
DR   STRING; 10116.ENSRNOP00000072295; -.
DR   iPTMnet; Q62915; -.
DR   PhosphoSitePlus; Q62915; -.
DR   SwissPalm; Q62915; -.
DR   jPOST; Q62915; -.
DR   PaxDb; 10116-ENSRNOP00000004187; -.
DR   ABCD; Q62915; 1 sequenced antibody.
DR   GeneID; 29647; -.
DR   KEGG; rno:29647; -.
DR   UCSC; RGD:62004; rat.
DR   AGR; RGD:62004; -.
DR   CTD; 8573; -.
DR   RGD; 62004; Cask.
DR   eggNOG; KOG0609; Eukaryota.
DR   InParanoid; Q62915; -.
DR   OrthoDB; 2873706at2759; -.
DR   PhylomeDB; Q62915; -.
DR   BRENDA; 2.7.11.1; 5301.
DR   Reactome; R-RNO-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   EvolutionaryTrace; Q62915; -.
DR   PRO; PR:Q62915; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0005604; C:basement membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0060170; C:ciliary membrane; IDA:BHF-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005652; C:nuclear lamina; ISO:RGD.
DR   GO; GO:0016363; C:nuclear matrix; ISO:RGD.
DR   GO; GO:0005730; C:nucleolus; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098846; C:podocyte foot; IDA:RGD.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0098793; C:presynapse; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0097060; C:synaptic membrane; IDA:BHF-UCL.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0042043; F:neurexin family protein binding; IPI:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0070509; P:calcium ion import; ISO:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0090288; P:negative regulation of cellular response to growth factor stimulus; ISO:RGD.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; ISO:RGD.
DR   GO; GO:0061045; P:negative regulation of wound healing; ISO:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; ISO:RGD.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; IMP:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; IBA:GO_Central.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IMP:RGD.
DR   GO; GO:0046928; P:regulation of neurotransmitter secretion; IBA:GO_Central.
DR   GO; GO:2000300; P:regulation of synaptic vesicle exocytosis; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:RGD.
DR   CDD; cd00071; GMPK; 1.
DR   CDD; cd00992; PDZ_signaling; 1.
DR   CDD; cd12081; SH3_CASK; 1.
DR   CDD; cd14094; STKc_CASK; 1.
DR   Gene3D; 2.30.42.10; -; 1.
DR   Gene3D; 6.10.140.620; -; 1.
DR   Gene3D; 1.10.287.650; L27 domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR035473; CASK_SH3.
DR   InterPro; IPR008145; GK/Ca_channel_bsu.
DR   InterPro; IPR008144; Guanylate_kin-like_dom.
DR   InterPro; IPR020590; Guanylate_kinase_CS.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR014775; L27_C.
DR   InterPro; IPR004172; L27_dom.
DR   InterPro; IPR036892; L27_dom_sf.
DR   InterPro; IPR050716; MAGUK.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR23122; MEMBRANE-ASSOCIATED GUANYLATE KINASE MAGUK; 1.
DR   PANTHER; PTHR23122:SF40; PERIPHERAL PLASMA MEMBRANE PROTEIN CASK; 1.
DR   Pfam; PF00625; Guanylate_kin; 1.
DR   Pfam; PF02828; L27; 2.
DR   Pfam; PF00595; PDZ; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF07653; SH3_2; 1.
DR   SMART; SM00072; GuKc; 1.
DR   SMART; SM00569; L27; 2.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF101288; L27 domain; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50156; PDZ domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   SUPFAM; SSF50044; SH3-domain; 1.
DR   PROSITE; PS00856; GUANYLATE_KINASE_1; 1.
DR   PROSITE; PS50052; GUANYLATE_KINASE_2; 1.
DR   PROSITE; PS51022; L27; 2.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Calmodulin-binding; Cell membrane; Cytoplasm;
KW   Kinase; Membrane; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Serine/threonine-protein kinase; SH3 domain;
KW   Transferase.
FT   CHAIN           1..909
FT                   /note="Peripheral plasma membrane protein CASK"
FT                   /id="PRO_0000094570"
FT   DOMAIN          12..276
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          343..398
FT                   /note="L27 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00365"
FT   DOMAIN          402..455
FT                   /note="L27 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00365"
FT   DOMAIN          489..564
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          600..670
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          722..894
FT                   /note="Guanylate kinase-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00100"
FT   REGION          305..315
FT                   /note="Calmodulin-binding"
FT   REGION          482..909
FT                   /note="Required for interaction with NRXN1 (via C-terminal
FT                   tail)"
FT                   /evidence="ECO:0000269|PubMed:25385611"
FT   REGION          574..598
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        141
FT                   /evidence="ECO:0000250"
FT   BINDING         18..26
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00100,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         41
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         51
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14936"
FT   MOD_RES         151
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14936"
FT   MOD_RES         155
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:O14936"
FT   MOD_RES         182
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O70589"
FT   MOD_RES         313
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O14936"
FT   HELIX           8..11
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          12..20
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          25..31
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   TURN            32..34
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          37..44
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           45..49
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           56..68
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          77..83
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          86..92
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           99..108
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           115..134
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           144..146
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          147..153
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           163..165
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           183..185
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           188..191
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           199..214
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           223..232
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           239..242
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           247..256
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   TURN            261..263
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           267..271
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           274..277
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           279..282
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           289..302
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   STRAND          304..306
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   HELIX           316..320
FT                   /evidence="ECO:0007829|PDB:6LNM"
FT   TURN            342..344
FT                   /evidence="ECO:0007829|PDB:1RSO"
FT   HELIX           345..359
FT                   /evidence="ECO:0007829|PDB:1RSO"
FT   HELIX           365..376
FT                   /evidence="ECO:0007829|PDB:1RSO"
FT   HELIX           378..391
FT                   /evidence="ECO:0007829|PDB:1RSO"
SQ   SEQUENCE   909 AA;  103259 MW;  3694A9A44AC29629 CRC64;
     MADDDVLFED VYELCEVIGK GPFSVVRRCI NRETGQQFAV KIVDVAKFTS SPGLSTEDLK
     REASICHMLK HPHIVELLET YSSDGMLYMV FEFMDGADLC FEIVKRADAG FVYSEAVASH
     YMRQILEALR YCHDNNIIHR DVKPHCVLLA SKENSAPVKL GGFGVAIQLG ESGLVAGGRV
     GTPHFMAPEV VKREPYGKPV DVWGCGVILF ILLSGCLPFY GTKERLFEGI IKGKYKMNPR
     QWSHISESAK DLVRRMLMLD PAERITVYEA LNHPWLKERD RYAYKIHLPE TVEQLRKFNA
     RRKLKGAVLA AVSSHKFNSF YGDPPEELPD FSEDPTSSGL LAAERAVSQV LDSLEEIHAL
     TDCSEKDLDF LHSVFQDQHL HTLLDLYDKI NTKSSPQIRN PPSDAVQRAK EVLEEISCYP
     ENNDAKELKR ILTQPHFMAL LQTHHVVAHE VYSDEALRVT PPPTSPYLNG DSPESANGDM
     DMENVTRVRL VQFQKNTDEP MGITLKMNEL NHCIVARIMH GGMIHRQGTL HVGDEIREIN
     GISVANQTVE QLQKMLREMR GSITFKIVPS YRTQSSSCER DSPSTSRQSP ANGHSSTNNS
     VSIYVRAQFE YDPAKDDLIP CKEAGIRFRV GDIIQIISKD DHNWWQGKLE NSKNGTAGLI
     PSPELQEWRV ACIAMEKTKQ EQQASCTWFG KKKKQYKDKY LAKHNADLVT YEEVVKLPAF
     KRKTLVLLGA HGVGRRHIKN TLITKHPERF AYPIPHTTRP PKKDEENGKN YYFVSHDQMM
     QDISNNEYLE YGSHEDAMYG TKLETIRKIH EQGLIAILDV EPQALKVLRT AEFPPFVVFI
     AAPTITPGLN EDESLQRLQK ESDVLQRTYA HYFDLTIINN EIDETIRHLE EAVELVCTAP
     QWVPVSWVY
//
